Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam in Cluster Epileptic Seizures
NCT00376766Phase 3Terminated
- Sponsor
- CHU Grenoble Alpes
- Start
- Feb 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of levetiracetam in epilepsy, sponsored by CHU Grenoble Alpes. Primary endpoint: Ratio of patients who are free of seizure between H3 and H24 at 24 hours. Started Feb 2007; status: terminated.
02
Drugs
levetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00376766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00376766.